Lack of efficacy of a partial adenosine A1 receptor agonist in neuropathic pain models in mice.

"Declarations Ethics approvalAll experiments were ethically reviewed and approved by our local Ethics Committee for Animal Research (Regierungspräsidium Darmstadt, Germany). Consent to participateNot applicable. Consent for publicationNot applicable. Conflicts of interestKatharina Metzner declares no conflict of interest.Tilman Groß declares no conflict of interest.Annika Balzulat declares no conflict of interest.Gesine Wack declares no conflict of interest.Ruirui Lu declares no conflict of interest.Achim Schmidtko declares no conflict of interest. Conflicts of interest Katharina Metzner declares no conflict of interest. Tilman Groß declares no conflict of interest. Annika Balzulat declares no conflict of interest. Gesine Wack declares no conflict of interest. Ruirui Lu declares no conflict of interest. Achim Schmidtko declares no conflict of interest."

"Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by the Grants4Indications™ initiative of Bayer AG, Leverkusen, Germany, and by European Regional Development Fund/LeitmarktAgentur.NRW (EFRE-0800971/LS-1–2-023d). The funding sources had no role in study design; the collection, analysis, and interpretation of data; or the writing of the manuscript and the decision to publish."